BioLineRx Reports Strong 2024 Financial Results and Strategic Advancements
PremiumCompany AnnouncementsBioLineRx Reports Strong 2024 Financial Results and Strategic Advancements
5d ago
Options Volatility and Implied Earnings Moves Today, March 31, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 31, 2025
5d ago
Options Volatility and Implied Earnings Moves This Week, March 31 – April 03, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 31 – April 03, 2025
5d ago
BioLineRx Adjusts ADS Ratio to Maintain Nasdaq Listing
PremiumCompany AnnouncementsBioLineRx Adjusts ADS Ratio to Maintain Nasdaq Listing
3M ago
BioLineRx changes ratio of ADRs to ordinary shares
Premium
The Fly
BioLineRx changes ratio of ADRs to ordinary shares
3M ago
BiolineRx Announces Major Direct Offering to Bolster Operations
Premium
Company Announcements
BiolineRx Announces Major Direct Offering to Bolster Operations
3M ago
BioLineRx price target lowered to $9 from $21 at H.C. Wainwright
PremiumThe FlyBioLineRx price target lowered to $9 from $21 at H.C. Wainwright
4M ago
BioLineRx Secures Key Deals to Boost Shareholder Value
Premium
Company Announcements
BioLineRx Secures Key Deals to Boost Shareholder Value
4M ago
BioLineRx reports Q3 EPS 0c vs. (2c) last year
Premium
The Fly
BioLineRx reports Q3 EPS 0c vs. (2c) last year
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100